Prognostic Factors/Neural Networks

Wajsman Z, Chu TM, Bross D, Saroff J, Murphy GP, Johnson DE, Scott, WW, Gibbons RP, Prout GR, Schmidt JD. Clinical significance of serum alkaline phosphatase isoenzyme levels in advanced prostatic carcinoma. J Urol 1977; 119(2):224-246.

Yarbro JW, Page DL, Fielding LP, Partridge EE, Murphy GP. American Joint Committee on Cancer Prognostic Factors Consensus Conference. Cancer 1999; 86(11):2436-2446.

Murphy GP, Snow P, Simmons SJ, Tjoa BA, Rogers MK, Brandt J, Healy CG, Bolton WE. The use of artifical neural networks in evaluating prognostic factors determining the response to dendritic cells pulsed with PSMA peptides in prostate cancer patients. Prostate 2000; 42(1):67-72.

Rodvold DM, McLeod DG, Brandt JM, Snow PB, Murphy GP. An introduction to artificial neural networks for physicians: taking the lid off the black box. Prostate 2001; 46(1):39-44.